The new drug uses a so-called cloaking device and only activates when it reaches the tumour ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...

Researchers at Moffitt Cancer Center have developed a new mouse model that more accurately reflects how uveal melanoma acts in humans. This could improve research, resulting in better patient outcomes ...

Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.

Advocate Condell Medical Center, 801 S. Milwaukee Ave., Libertyville, last month became one of the first facilities in the nation to address metastatic cancer in the lung using the ...

Purchase funded by the Thomas Foundation following FDA marketing authorization of ProSense (R) in low-risk breast cancer and inclusion of cryoablation in proposed medical society guidelines ...

A research team at the University of Missouri has treated the first cancer patient with a new nuclear medicine device that targets tumors inside the liver. The early-stage clinical trial focuses on ...

Researchers at Tezpur University in India have identified a panel of circulating microRNAs in blood serum that may help distinguish gallbladder cancer from benign conditions, offering a potential ...

A phase 2 trial showed that combining targeted radiotherapy with PD-1 blockade and a bevacizumab biosimilar can elicit responses in advanced liver cancer.

Indraprastha Apollo Hospitals has launched the Varian Edge® Radiosurgery System with Hyperarc Technology, strengthening its advanced cancer care capabilities and ...